Log In
Print this Print this

FT228, Medusa Exenatide XL

  Manage Alerts
Collapse Summary General Information
Company Flamel Technologies S.A.
DescriptionOnce-weekly formulation of exenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist, delivered using the Medusa drug delivery platform
Molecular Target Glucagon-like peptide-1 (GLP-1)
Mechanism of ActionGlucagon-like peptide-1 (GLP-1) receptor agonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat diabetes; Treat Type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today